Effects of Family History on Relative and Absolute Risks for Colorectal Cancer: A Systematic Review and Meta-Analysis

Autor: Roos V, Mangas-Sanjuan C, Rodriguez-Girondo M, Medina-Prado L, Steyerberg E, Bossuyt P, Dekker E, Jover R, van Leerdam M

Publikováno v: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
instname

Guidelines recommend that individuals with familial colorectal cancer undergo colonoscopy surveillance instead of average-risk screening. However, these recommendations vary widely. To substantiate appropriate surveillance strategies, precise and val

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::f6d8f9f5e1c6cff77942b834dfedacfb
https://fundanet.isabial.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=5460

Performance of BRCA1/2 mutation prediction models in male breast cancer patients

Autor: Moghadasi, S., Grundeken, V., Janssen, L.A.M., Dijkstra, N.H., Rodriguez-Girondo, M., Zelst-Stams, W.A.G. van, Oosterwijk, J.C., Ausems, M.G.E.M., Oldenburg, R.A., Adank, M.A., Blom, E.W., Ruijs, M.W.G., Os, T.A.M. van, Deurzen, C.H.M. van, Martens, J.W.M., Schroder, C.P., Wijnen, J.T., Vreeswijk, M.P.G., Asperen, C.J. van

Publikováno v: Clinical Genetics, 93(1), 52-59. Wiley-Blackwell
Clinical Genetics
Clinical genetics, 93(1), 52-59. Wiley-Blackwell
Clinical Genetics, 93(1), 52-59. Wiley
Clinical Genetics, 93(1), 52-59. Wiley-Blackwell Publishing Ltd
Moghadasi, S, Grundeken, V, Janssen, L A M, Dijkstra, N H, Rodríguez-Girondo, M, van Zelst-Stams, W A G, Oosterwijk, J C, Ausems, M G E M, Oldenburg, R A, Adank, M A, Blom, E W, Ruijs, M W G, van Os, T A M, van Deurzen, C H M, Martens, J W M, Schroder, C P, Wijnen, J T, Vreeswijk, M P G & van Asperen, C J 2018, ' Performance of BRCA1/2 mutation prediction models in male breast cancer patients ', Clinical Genetics, vol. 93, no. 1, pp. 52-59 . https://doi.org/10.1111/cge.13065

To establish whether existing mutation prediction models can identify which male breast cancer (MBC) patients should be offered BRCA1 and BRCA2 diagnostic DNA screening, we compared the performance of BOADICEA (Breast and Ovarian Analysis of Disease

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::5e45b06f49d42d92d16cf4f7cbc8df09
https://research.vumc.nl/en/publications/380b6b64-8984-4d28-ac02-afc2d785d636

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.